ACTIVE

P&G HEALTH BELGIUM

Export PDF

Financial year 2020 · Closed on 30/06/2020

Net result8,2 M €+174,6 %over 1 year
Revenue49,3 M €+56,9 %over 1 year
Equity29,9 M €+50,5 %over 1 year
Workforce49,6 ETP-6,4 %over 1 year

Identity

Source · BCE/KBO

P&G HEALTH BELGIUM is a Private limited company incorporated in 1997. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Grimbergen. It employs on average 49,6 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0461.017.640
Incorporation
03/07/1997
Legal form
Private limited company
Registered office
Temselaan 100
1853 Grimbergen · FlandreSee on map
Latest accounts
30/06/2020
Average workforce
49,6 ETP
Joint committees (2)
  • 200
  • 218
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

Financials

Source · NBB, 21 filings

Trend over 13 financial years

20202017201620152014
Income statement
Revenue49,3 M €31,4 M €32,5 M €32 M €31,8 M €
EBITDA12,3 M €4,7 M €3,1 M €4,2 M €7,9 M €
Operating result11,8 M €4,7 M €3,3 M €4 M €7,9 M €
Net result8,2 M €3 M €2,2 M €2,6 M €5,1 M €
Balance sheet
Equity29,9 M €19,9 M €16,9 M €15,5 M €13,8 M €
Total assets36,2 M €23,5 M €21,9 M €19,4 M €16,7 M €
Cash1,3 M €––––
Debts5,8 M €3,7 M €5 M €3,8 M €2,9 M €
Other
Workforce49,6 ETP53,0 ETP49,7 ETP47,8 ETP47,2 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 50 M€ and 100 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2017

3 active · 25 ended

Last known composition, from the accounts closed on 31/12/2017, more than two years before the latest accounts. The mandates shown may have expired.

Active mandates

Ronald Rahi

Director · since 27 avril 2017 · until 27 avril 2023

Active
Ariane Misonne

Director · since 02 février 2016 · until 18 juin 2021

Active
Jean-Pierre Darriot

Director · since 01 février 2016 · until 27 avril 2017

Active

Ended mandates

Ariane Misonne

Managing director · since 02 février 2016 · until 18 juin 2021

Ended
Jean-Pierre Darriot

Director · since 01 février 2016 · until 18 juin 2021

Ended
Björn Hermes

Director · since 01 janvier 2014 · until 17 décembre 2015

Ended
Björn Hermes

Director · since 01 janvier 2014 · until 14 mars 2019

Ended

Other companies at this address

Temselaan 100 1853 Grimbergen
CompanyCBE no.
ANACON● Active
0828.515.503
ANACON INVESTMENTS● Active
0542.854.263
ATK-solutions.be● Active
1037.802.604
A.Y DISTRIBUTION● Active
1022.885.289
Bakels Consultancy● Bankrupt
0745.677.602
BOULDER● Active
0462.438.986
CLEAN YOUR LIFE● Active
1001.580.428
CONSTRUCT MANAGEMENT RENDERS● Active
0474.183.015
Customs Easy● Active
0763.820.362
DanceForce● Active
1016.113.008
DEPANNELEC● Active
0776.747.492
DORIAN GROEP● Active
0837.393.377
DS PROJETS● Active
1019.608.867
GILSON'S● Active
0422.491.220
HELP4YOU● Active
0690.681.570
IBO SOLUTIONS● Active
1009.460.390
IMOYA● Active
0443.480.238
IMOYA HOLDING● Active
0740.492.060
Imoya Projects● Active
0556.637.963
IMOYA PROJECTS RESIDENTIAL● Active
0693.742.218

Full financial information

Source · NBB
202520242023202220212020
Type of accountFull modelFull modelFull modelFull modelFull modelFull model
Start of the financial year01/07/202401/07/202301/07/202201/07/202101/07/202001/01/2019
Closing of the financial year30/06/202530/06/202430/06/202330/06/202230/06/202130/06/2020
Length of the financial year12 months12 months12 months12 months12 months18 months
Filing date24/11/202519/11/202416/11/202328/11/202221/02/202214/12/2020
General meeting03/11/202504/11/202403/11/202303/11/202203/11/202110/12/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 21 filings
ModelClosingGeneral meetingFiledLanguageDocument
Full model30/06/202503/11/202524/11/2025DutchPDF
Full model30/06/202404/11/202419/11/2024DutchPDF
Full model30/06/202303/11/202316/11/2023DutchPDF
Full model30/06/202203/11/202228/11/2022DutchPDF
Full modelCorrection30/06/202103/11/202121/02/2022DutchPDF
Full modelCorrection30/06/202103/11/202121/02/2022DutchPDF
Full model30/06/202103/11/202118/11/2021DutchPDF
Full model30/06/202010/12/202014/12/2020DutchPDF
Full model31/12/201821/06/201927/06/2019DutchPDF
Full model31/12/201715/06/201819/06/2018DutchPDF
Full model31/12/201630/06/201705/07/2017DutchPDF
Full model31/12/201517/06/201624/06/2016DutchPDF
Full model31/12/201429/06/201507/07/2015DutchPDF
Full model31/12/201327/05/201430/06/2014DutchPDF
Full model31/12/201229/03/201314/06/2013DutchPDF
Full model31/12/201128/03/201207/06/2012DutchPDF
Full model31/12/201003/05/201120/10/2011DutchPDF
Full model31/12/200929/06/201008/07/2010DutchPDF
Full model31/12/200829/06/201008/07/2010DutchPDF
Abridged model31/12/200719/06/200817/07/2008DutchPDF
Abridged model31/12/200621/06/200716/08/2007DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 50 M€ and 100 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2017

3 active · 25 ended

Last known composition, from the accounts closed on 31/12/2017, more than two years before the latest accounts. The mandates shown may have expired.

Active mandates

Ronald Rahi

Director · since 27 avril 2017 · until 27 avril 2023

Active
Ariane Misonne

Director · since 02 février 2016 · until 18 juin 2021

Active
Jean-Pierre Darriot

Director · since 01 février 2016 · until 27 avril 2017

Active

Ended mandates

Ariane Misonne

Managing director · since 02 février 2016 · until 18 juin 2021

Ended
Jean-Pierre Darriot

Director · since 01 février 2016 · until 18 juin 2021

Ended
Björn Hermes

Director · since 01 janvier 2014 · until 17 décembre 2015

Ended
Björn Hermes

Director · since 01 janvier 2014 · until 14 mars 2019

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates31/12/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates13/11/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates16/12/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates06/12/2023
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates22/11/2022
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates20/04/2022
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates31/03/2022
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates02/03/2022
    ONTSLAGEN - BENOEMINGEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2020
    Annual accounts 20208,2 M €↑
  2. 2020
    Name changeP&G HEALTH BELGIUM
  3. 2017
    Annual accounts 20173 M €↑
  4. 2016
    Annual accounts 20162,2 M €↓
  5. 2015
    Annual accounts 20152,6 M €↓
  6. 2014
    Annual accounts 20145,1 M €↑
  7. 2013
    Annual accounts 20135,1 M €↑
  8. 2012
    Annual accounts 20124,6 M €↑
  9. 2011
    Annual accounts 20114,4 M €↑
  10. 2010
    Annual accounts 20104,1 M €↓
  11. 2009
    Annual accounts 20094,2 M €↑
  12. 2008
    Annual accounts 2008962,4 k €↓
  13. 2008
    Name changeMerck Consumer Healthcare
  14. 2007
    Annual accounts 20071,5 M €↓
  15. 2006
    Annual accounts 20061,6 M €
  16. 2006
    Name changeBIO - FYT pharma
  17. 03/07/1997
    IncorporationPrivate limited company